SPOTLIGHT -
Sales presentation for BD Ophthalmics
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410
(EyePod) From idea to impact: Navigating ophthalmic innovation
Intracortical Visual Prosthesis achieves 2 years of successful testing
EyePod: Modifier Gene Therapy: What is it?
Using extracellular vesicles in the treatment of ocular diseases
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy